Home > Financial Ratios > HESTER BIOSCIENCES

HESTER BIOSCIENCES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for HESTER BIOSCIENCES
Please provide your vote to see the results

HESTER BIOSCIENCES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 48.271.06-2.23-10.800.52

What is the latest Core EBITDA Growth ratio of HESTER BIOSCIENCES ?

The latest Core EBITDA Growth ratio of HESTER BIOSCIENCES is 48.27 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202648.27
Mar20251.06
Mar2024-2.23
Mar2023-10.80
Mar20220.52

How is Core EBITDA Growth of HESTER BIOSCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2026 48.27
4,453.77
Mar2025 1.06
Positive
Mar2024 -2.23
Negative
Mar2023 -10.8
Negative
Mar2022 0.52 -

Other Financial Ratios of HESTER BIOSCIENCES


Compare Core EBITDA Growth ratio of peers of HESTER BIOSCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HESTER BIOSCIENCES ₹1,848.2 Cr -1.2% -3.8% 10.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,679.0 Cr -1.8% -7% 14.3% Stock Analytics
DIVIS LABORATORIES ₹246,408.0 Cr -3.4% 0.4% 58.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,634.0 Cr -2.7% -3.6% 36% Stock Analytics
CIPLA ₹109,063.0 Cr -3.9% -4.7% -10.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,166.0 Cr 3% 6.1% -3.8% Stock Analytics


HESTER BIOSCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HESTER BIOSCIENCES

-1.2%

-3.8%

10.1%

SENSEX

-3.1%

-6.2%

-11.7%


You may also like the below Video Courses